I did a screen EPS over 5 next 5, Debt less than 50%.  Return on E over 20.  No dividend.  P/B less than 4.

COB-COMMUNITYONE BANCORP-selling at 12.49.  P/E is 1.82.  Cap is 303m.  Short is at 1%.  Analysts are very bearish.  Book is 11.31.  They have 26% expectation of eps growth this coming year.  Book is growing at 39%.  Return on equity is at 55.87.  They have 51% debt to equity.  They were super unprofitable for a long time.  Now their earnings are unsteady.  RonE is at very weird figures.  I can only say, they are not reliable.  They are getting bought for  14.25 per share.  There is not a lot of volume.  I’ll set a price alert for 10.  If it goes down, I’ll look into the arb opportunity.

EMKR-EMCORE CORP-They are up 9% on the year, selling at 5.66. No dividend.  Cap is 145m.  P/E is non existent.  Analysts are very bearish.  Book is 5.28.  Earnings are supposed to skyrocket this year with 54.55% growth.  Book has been growing at 3.61.  Return on equity is negative.  No debt figures.  I guess guys are a broadband and fibre optics commodity producer.  Insiders own 10.6%.  It would be a gift to call return on equity figures growth 3.61.  They have a big book, and, upon review, a lot of hidden value.  So lets say they grow to 7.53, and we call one of their pops and we have eps of 3.76, and lets give em a p/e of 2, they could have a price of 7.53.  I’d buy em for 2.

HIBB-HIBBETT SPORTS INC-Sells at their 52 week low.  Short interest is 23.74.  P/E is at 10.  EPS would be 2.949.  Analysts are very bullish…on the short?  Book is 12.93.  Their growth figures are great.  7.61 this year.  8.64 coming 305.  Book growth is at 13.15.  Return on equity is at 22.58.  Debt is at .88%.   They are a retailer but they’ve been growing ok.  Return on equity is always really high like 22+, so I’ll just say 20.  Cap is at 678m.  We’ll use a p/e of 8 moving forward.  We’ll also compound our book at 12.  That would give us book of 40.16, and thus a 8eps with a 20% gain in year 10.  With a p/e of 8, we could see a price of 64.  I’d buy for 15.5.

SCSS-SELECT COMFORT-We’re looking at a price of 19.86, 52 week low. P/E is 11.55.  Short interest is at 5.82.  Cap is 1.01b.  Analysts are positive/neutral.  Book is 5.37.  Book grows at 62.  EPS growth is at 17.  Forward, 15.8.  Return on equity is at 34.38.  Debt is o.  Earnings are pretty good, maybe spotty, but they have a really bad quarter coming.  Why?  Insiders own like 4%.  Insiders are buying, not really selling. Return on equity is always awesome.  We’ll say 20, but its a lot higher.  Checked reviews, they are not loved.  We’ll say book in 10 of 33.25, and earnings of 6.65 and perhaps a share price of 66.5 with a 10 p/e…but lets go with a 9 p/e and thus we have a price of 59.85.  I’ll buy it up at 15.  Crazy stupid value.

SYNT-SYNTEL INC-is trading at 44.34.  Near their 52 week low.  Cap is 3.72.  P/E is 14.98.  EPS of 2.959.  Analysts are VERY bullish.  Book is at 13.01 per share.  Short interest is at 1.36.  EPS growth is 6.6 this coming year.  EPS in 3-5 is at 15.  Book growth is at 22.05.  Return on equity 24.36.  Debt to equity 6%.  This company grows excellently.  Insider ownership is at like 5.5%. Return on equity is always huge like 22+.   This company provides IT and knowledge process outsourcing.  SEE also Wipro and genpact.  KPO is more skilled work than outsourcing data entry, payroll, bookkeeping, etc.  It looks like they could get in trouble if they lose their amex or fedex contracts.  Let’s see.  Let’s say book grows at only 17, that gives us book of 62.54, and thus EPS of 10.63, and with the p/e of 14, we’ll see a valuation of 148.82.  This is a great company.  I’d buy em now, but I’d be in great shape at 42.

TARO-TARO PHARMACEUTICAL INDUSTRIES LTD-Trading at 144.92, near their 52 week low.  Cap is 6.21b.  Short interest is .81.  P/E is 11.67.  EPS is 12.33.  Analysts are very bearish. Book is 37.59 per share.  EPS in coming years is not estimated.  Book growth is at 36.96.  Return on equity is at 36.32. Debt is at .29%.  Earnings are pretty steady with healthy bumps.  Return on equity is always really, really high.  So what’s the deal here: price held down by conflicting managing interests.  A larger company is milking our guy here.   Serious management questions.  I think this company is a monkey to sun pharma.  I like the idea of investing in fundamentals though.  So at a 17 rate of growth, we’ll have 180.69 in book, and thus 30.71 in EPS and thus 307 with a p/e of 12.  That’s some real conservative rejiggering.  Eh, I don’t like scummy self-interested boards.  I’ll buy em at 110.

VNDA-VANDA PHARMACEUTICALS INC-Price is at 8.83.  52 week low is at 8.  P/E is 748.  Short interest is at 18%.  Cap is 378.06.  Analysts are very bearish.  Book is 3.41 per share.  Book growth is at 47%.  Retrn on equity is at 29.33.  Debt is none.  With 20% rate, we’ll see book of 21.11, and thus 4.222 in EPS, and thus with a 9 p/e a price of say 38.  They are buyable with this range, but what’s the problem here.  There is something scammy here.  I’d buy at 5.